ITEM METADATA RECORD
Title: Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine
Authors: Cortes, Javier ×
Vahdat, Linda
Blum, Joanne L
Twelves, Chris
Campone, Mario
Roché, Henri
Bachelot, Thomas
Awada, Ahmad
Paridaens, Robert
Goncalves, Anthony
Shuster, Dale E
Wanders, Jantien
Fang, Fang
Gurnani, Renuka
Richmond, Elaine
Cole, Patricia E
Ashworth, Simon
Allison, Mary Ann #
Issue Date: Sep-2010
Publisher: Grune & Stratton
Series Title: Journal of Clinical Oncology vol:28 issue:25 pages:3922-3928
Abstract: The activity and safety of eribulin mesylate (E7389), a nontaxane microtubule dynamics inhibitor with a novel mechanism of action, were evaluated in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, taxane, and capecitabine.
URI: 
ISSN: 0732-183X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Experimental Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy

 




All items in Lirias are protected by copyright, with all rights reserved.

© Web of science